Waltermire Robert E.

Senior VP, Chief Pharma Dev. of MDGL

Stock Insider Trading Activity of Waltermire Robert E.

Name	Ticker	Relationship	Date	Transaction	AVG Cost Per Share	Shares	Total Value	Securities Owned After Transaction(s)	SEC Form 4
Waltermire Robert E.	MDGL	Senior VP, Chief Pharma Dev.	Jan 17 '25	Sell	$273.41	442	$120,847.22	5,058	SEC Form 4